no company logocircle

TSA member, Pivotell, launches the first antibacterial automatic pill dispenser

Posted on 01 May, 2018

From May 2018 Pivotell dispensers will incorporate a premium silver ion technology that is introduced during the manufacturing stage to provide the ultimate protection against harmful microbes such as bacteria, mould and even viruses.

The new dispensers have demonstrated reductions of over 99.9% in cross contamination, and set the bar even higher for the medication management market. The models to include this technology are Pivotell Advance and Mk3/11 dispensers.

Pivotell Director Nicky Green (right) with BioCote’s Guy Charteris and the new antimicrobial pill dispenser

Automatic pill dispensers are used by health and social care professional as an integral component of a targeted care package for medically compromised and vulnerable adults – primarily in their own homes – who have difficulty managing their medication. This can be either stand alone, include alert messaging, or be linked to Telecare Lifeline response.

BioCote technology makes the dispenser inherently more hygienic and addresses a recognised problem within carousel medication delivery: cross contamination. Crucially, the devices are now easier to keep hygienically clean for the patients, their family and visiting carers, plus pharmacists and their staff who are all regularly handling the device.

When manufactured into products and materials. antimicrobial technology creates surfaces upon which microbes cannot survive. It reduces bacteria and mould almost entirely and even antibiotic resistant strains of bacteria like MRSA, E.coli, Salmonella and Candida auris are eliminated. It has even been proven to deactivate the H1N1 influenza virus – this technology will last for the functional lifetime of any product it is integrated into.

BioCote is used across many applications including health, education, food and catering, home and leisure.

For more information please contact:

Pivotell Ltd on +44 (0) 1799 550979

Share this page:

Partners & Associates